delete National Health (Pharmaceutical Benefits) Regulations (Amendment)
Amends the National Health (Pharmaceutical Benefits) Regulations, which govern the Pharmaceutical Benefits Scheme (PBS). Without the full text, the amendment's specific changes are unknown but likely modify eligibility, co-payments, drug listing criteria, or administrative processes for subsidized medicines.
Keeping this amendment sustains the PBS, a costly welfare program that distorts pharmaceutical markets. Unseen costs include moral hazard (overconsumption), inflated prices due to government price-setting, reduced competition from listing barriers, bureaucratic overhead, and higher taxes. The goal of affordable medicines is better achieved through market competition and private charity, not state intervention.